ArticleAntioxidants (Basel, Switzerland)2022

Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease.

Neda Anastassova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.